甘李药业: 关于公司2022年限制性股票激励计划第二个解除限售期解除限售条件成就的公告

Core Viewpoint - The announcement details the achievement of conditions for the second unlock period of the 2022 restricted stock incentive plan of Ganli Pharmaceutical, allowing 125 eligible participants to unlock a total of 1,121,760 shares [1][9][12] Summary by Sections 1. Approval and Implementation of the Incentive Plan - The incentive plan was approved on October 24, 2022, during the fourth board meeting, with independent directors expressing agreement [2] - The list of incentive objects was disclosed on October 25, 2022, and no objections were raised during the public notice period [2] - The first extraordinary general meeting of shareholders approved the plan on November 15, 2022 [2] - Adjustments to the incentive object list were made on November 28, 2022, with independent directors and the supervisory board agreeing [3] 2. Conditions for Unlocking Shares - The second unlock period has been reached, with the unlock conditions specified in the incentive plan [4] - The second unlock period conditions include no negative audit opinions on financial reports and no disqualifications of incentive objects [5][6][7] - The company achieved a net profit of 6.15 billion for the 2024 fiscal year, exceeding the required 6 billion, thus meeting the performance criteria for the second unlock period [9] 3. Specifics of the Unlocking Process - A total of 112.176 million shares will be unlocked, representing 29.98% of the total granted shares [4][11] - The unlocking procedures will be completed after the 2024 profit distribution, with a subsequent announcement to investors [4] - The incentive plan allows for annual assessments of the incentive objects, determining the proportion of shares that can be unlocked based on individual performance [8][10] 4. Opinions from Committees - The Compensation and Assessment Committee confirmed that the conditions for the second unlock period have been met and that the 125 eligible participants are legally qualified [9] - The supervisory board also agreed that the conditions for unlocking shares are in compliance with relevant regulations and the incentive plan [10]